European shares close at fresh record high as Novo Nordisk drives healthcare boost
EUROPEAN shares closed at a new peak on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo Nordisk clinched US…
Tag
EUROPEAN shares closed at a new peak on Tuesday, powered by gains in the healthcare sector, after heavyweight Novo Nordisk clinched US…
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo…
Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in…
Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5 per cent of its workforce, in a restructuring to save eight billion Danish…
European shares finished marginally higher on Monday (Sep 1), supported by defence stocks, while Novo Nordisk gained after data showed its…
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, with the Singapore…
Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Shares in the Danish…
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiatives Obesity drugmaker Novo Nordisk…
Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and…
EUROPE’S Stoxx 600 closed slightly higher at the start of a holiday-shortened week, as a spike in Novo Nordisk shares boosted the…
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuan Novo Nordisk said on Monday (Nov 18) it has launched its…